Ardent Health Partners (ARDT) Stock Price, News & Analysis

Company Overview

Ardent Health Partners, Inc. owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee. Ardent Health Partners, Inc. is a subsidiary of EGI-AM Investments, L.L.C.

Key Stats

• Today's Range: $13.77 to $14.96
• 50-Day Range: $13.75 to $17.08
• 52-Week Range: $13.63 to $20.72
• Volume: 527,624 shs
• Average Volume: 337,948 shs
• Market Capitalization: $1.98 billion
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $21.55
• Consensus Rating: Buy

ARDT Stock Analysis - Frequently Asked Questions

How have ARDT shares performed this year?

Ardent Health Partners' stock was trading at $17.08 on January 1st, 2025. Since then, ARDT shares have decreased by 18.9% and is now trading at $13.86.
View the best growth stocks for 2025 here.

How were Ardent Health Partners' earnings last quarter?

Ardent Health Partners, LLC (NYSE:ARDT) issued its quarterly earnings results on Wednesday, November, 6th. The company reported $0.19 EPS for the quarter, missing analysts' consensus estimates of $0.29 by $0.10. The business earned $1.45 billion during the quarter, compared to the consensus estimate of $1.46 billion.

When did Ardent Health Partners IPO?

Ardent Health Partners (ARDT) raised $192 million in an initial public offering on Thursday, July 18th 2024. The company issued 12,000,000 shares at $16.00 per share.

When did Ardent Health Partners' lock-up period expire?

Ardent Health Partners' lock-up period expired on Tuesday, January 14th. Ardent Health Partners had issued 12,000,000 shares in its IPO on July 18th. The total size of the offering was $192,000,000 based on an initial share price of $16.00. Since the end of Ardent Health Partners' lock-up period, restrictions preventing company insiders and major shareholders from selling shares in the company have been lifted.

Who are Ardent Health Partners' major shareholders?

Ardent Health Partners' top institutional investors include Ventas Inc. (6.55%), Point72 Asset Management L.P. (1.13%), Wellington Management Group LLP (1.09%) and Franklin Resources Inc. (0.64%).

How do I buy shares of Ardent Health Partners?

Shares of ARDT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Ardent Health Partners own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Ardent Health Partners investors own include Broadcom (AVGO), 4D Molecular Therapeutics (FDMT), Mirum Pharmaceuticals (MIRM), Micron Technology (MU), Uber Technologies (UBER), Advanced Micro Devices (AMD) and ASML (ASML).

Company Calendar

• Last Earnings: 11/06/2024
• Today: 2/21/2025
• Next Earnings (Confirmed): 2/26/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Medical
• Industry: General medical & surgical hospitals
• Sub-Industry: Healthcare
• Current Symbol: NYSE:ARDT
• Previous Symbol: NYSE:ARDT
• CUSIP: N/A
• CIK: 1756655
• Web: N/A
• Phone: (615) 296-3000
• Fax: N/A
• Employees: 24,200
• Year Founded: N/A

Price Target and Rating

• Average Stock Price Target: $21.55
• High Stock Price Target: $25.00
• Low Stock Price Target: $18.00
• Potential Upside/Downside: +55.5%
• Consensus Rating: Buy
• Rating Score (0-4): 3.00
• Research Coverage: 12 Analysts

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: 0.78
• Current Ratio: 1.91
• Quick Ratio: 1.78

Sales & Book Value

• Annual Sales: $5.41 billion
• Price / Sales: 0.37
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 142,730,000
• Free Float: N/A
• Market Cap: $1.98 billion
• Optionable: Optionable
• Beta: N/A